Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 19 July 2014, Vol 293, No 7819

Sort by: Newest first Oldest first A-Z Z-A

  • GPhC-inspections-runaway-train-14

    New GPhC premises inspection: why we need to stop this runaway train

    18 JUL 2014 By Graham Phillips
    Comments (3)

    The more I learn of the new inspection model the more concerned I become.

  • france-flag-senate-14

    French under fire from industry over off-label drug plans

    18 JUL 2014 0:00

    New law would allow doctors prescribe medicines for unlicensed indications.

  • Greater protection for IP could limit access to affordable medicines

    18 JUL 2014 0:00

    Access to affordable medicines could be threatened by a proposal to define intellectual property as an investment and include it in a trade and investment agreement being negotiated between the European Union (EU) and the United States.

  • pharmacist-tutor-postgraduate-14

    Shaping a pharmacist's formative years Subscription

    18 JUL 2014 0:00 By Gareth Nickless

    Pharmacists undertaking postgraduate diplomas need adequate support throughout the course, and tutors should be familiar with practice-based assessment.

  • Amoxicillin in infants drug alert Subscription

    18 JUL 2014 0:00

    A class four drug alert, caution in use, has been issued for amoxicillin sodium 250mg, 500mg and 1mg powder for solution for injection from Wockhardt. This is due to a number of reports of extravasation and injection site reactions in infants less than one year old and the medicine should not be used in these patients.

  • Everolimus angioedema risk Subscription

    18 JUL 2014 0:00

    Patients taking everolimus (Votubia; Novartis) and concomitant angiotensin-converting enzyme (ACE) inhibitor therapy, such as ramipril, may be at increased risk of angioedema, according to the updated summary of product characteristics.

  • TB drug resource Subscription

    18 JUL 2014 0:00

    A website has been launched called that contains detailed guidance and resources for the monitoring of adverse effects and safe use of tuberculosis medicines. It also includes drug monographs, recommended blood tests and updates to drug information.

  • Tuesday 22 July: South West London and London South East Subscription

    18 JUL 2014

    “Optimising the use of medicines in hypertension” local practice forum meeting by Helen Williams, consultant pharmacist. JG1004, Kingston University, Penrhyn Road, Kingston Upon Thames, Surrey KT1 2EE. Buffet 7pm, meeting 7.30pm.

  • Kenneth Charles Wibley dies Subscription

    18 JUL 2014

    On 29 May 2014, Kenneth Charles Wibley, aged 89, of 10 Grosvenor Heights, 2 Wyndham Road, Lower Parkstone, Poole, Dorset BH14 8SR. Mr Wibley registered in 1950 and left the Society in 2006.

  • UK-leaving-EU-14

    UK industry would be weakened by exit from EU Subscription

    18 JUL 2014 By John Chave

    Leaving the European Union would mean less political influence on medicines directives and yet the same regulatory obligations.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.